We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine
Published Online:https://doi.org/10.2217/pme-2016-0078

The Genetic Information Nondiscrimination Act (GINA) was intended to protect individuals in the USA from discrimination based on their genetic data, but does not apply to life, long-term care or disability insurance. Patient advocates and ethicists have argued that GINA does not go far enough. Others express concerns for the viability of insurance companies if millions of potential customers know more than professional actuaries. Here we discuss the exclusion of certain insurance types from GINA. We explore the ethical and economic implications of this distinction, and potential paths forward. We suggest that because long-term care and disability insurance can be essential for well-being, there is no good reason to place them in a class with life insurance and therefore beyond GINA's reach.

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

  • 1 Tenenbaum JD, James A, Paulyson-Nunez K. An altered treatment plan based on direct to consumer (DTC) genetic testing: personalized medicine from the patient/pin-cushion perspective. J. Pers. Med. 2(4), 192–200 (2012). • Gives a real-life example of the uncertainty of significance of genetic data in the dynamic landscape of guidelines for genomic medicine.
  • 2 Collins F. NIH head Francis Collins on new efforts to use medical records of volunteers to treat diseases. The Diane Rehm Show (2015). http://thedianerehmshow.org/shows/2015-09-28/nih-head-francis-collins-on-new-efforts-to-use-medical-records-of-volunteers-to-treat-diseases.
  • 3 US Congress. The Genetic Information Nondiscrimination Act of 2008 (2008). www.eeoc.gov/laws/statutes/gina.cfm.
  • 4 Papadimos TJ. Healthcare access as a right, not a privilege: a construct of Western thought. Philos. Ethics. Humanit. Med. 2(1), 2 (2007). •• This piece puts forth a key underlying tenet of our argument, that human beings have a fundamental.
  • 5 Maruthappu M, Ologunde R, Gunarajasingam A. Is health care a right? Health reforms in the USA and their impact upon the concept of care. Ann. Med. Surg. (Lond). 2(1), 15–17 (2013).
  • 6 McGuire AL, Majumder MA. Two cheers for GINA? Genome Med. 1(1), 6 (2009).
  • 7 McCall N. Who will pay for long term care? In: Long Term Care: Definition, Demand, Cost, And Financing. Health Administration Press, Chicago, IL, USA, 3–31 (2001).
  • 8 Shulman MA, Myles PS, Chan MT, McIlroy DR, Wallace S, Ponsford J. Measurement of disability-free survival after surgery. Anesthesiology 122(3), 524–536 (2015).
  • 9 Ioannidis JP. Why most published research findings are false. Chance 18(4), 40–47 (2005).
  • 10 California Insurance Code 2.5 (2011). http://law.justia.com/codes/california/2011/ins/division-2/10140-10145.4/.
  • 11 Parkman AA, Foland J, Anderson B et al. Public awareness of genetic nondiscrimination laws in four states and perceived importance of life insurance protections. J. Genet. Couns. 24(3), 512–521 (2015).
  • 12 Goodman K. Ethics, Medicine, and Information Technology: Intelligent Machines and the Transformation of Health Care. Cambridge University Press, Cambridge, UK (2015).
  • 13 US Congress. American Recovery and Reinvestment Act of 2009 (2009). www.congress.gov/bill/111th-congress/house-bill/1/text.
  • 14 Rothstein MA, Talbott MK. Compelled authorizations for disclosure of health records: magnitude and implications. Am. J. Bioeth. 7(3), 38–45 (2007).
  • 15 Rosenbaum S. New directions for health insurance design: implications for public health policy and practice. J. Law Med. Ethics 31(Suppl. 4), 94–103 (2003).